Federal Judges v. Science

Katie Wells was born in 1981 with serious birth defects. Her parents attributed them to a contraceptive jelly and sued the maker, Ortho Pharmaceutical Judge Marvin Shoob of the U.S. District Court in Georgia ruled they had proved their case and assessed $5 million in damages against Ortho. The Court of Appeals declined to overturn the judgment and last month the Supreme Court refused to intervene. What is wrong with that? First, the facts. Scientific experts often differ and the courts generally


Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

First, the facts. Scientific experts often differ and the courts generally decide, with some skill, which to believe. But with spermicides like Ortho's there is no serious difference among experts. After reviewing some 20 epidemiological studies, an expert committee advised the Food and Drug Administration in 1983 that the preponderance of available evidence "indicates no association" between spermicides and birth defects.

How then could Judge Shoob have ruled otherwise? Despite the written evidence of the scientific literature, he focused on the real testimony given in his court, and says he "paid close attention to each expert's demeanor and tone." Ortho's witnesses included prominent epidemiologists but were gravely deficient in the demeanor department.

One had impressive credentials, Judge Shoob conceded yet "lacked credibility." Of another, the judge said "his overall demeanor and manner indicated a degree of bias." He cited objective grounds for doubting one main witness, who had not disclosed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide